fluoxetine has been researched along with Infectious Myelitis in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated the following 3 widely used empirical therapies for the ability to reduce the severity of paralysis in a mouse model of EV-D68 infection: (1) human intravenous immunoglobulin (hIVIG), (2) fluoxetine, and (3) dexamethasone." | 3.85 | Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis. ( Clarke, P; Hixon, AM; Tyler, KL, 2017) |
| "Acute flaccid myelitis (AFM) is a rare condition associated with spinal cord gray matter abnormalities and frequent persistent motor deficits in the limbs." | 1.51 | Acute Flaccid Myelitis: Characteristics and Outcomes of 2014 and 2016 Cases at a Single Center. ( Hopkins, S; Matesanz, S; McGuire, JL, 2019) |
| "Fluoxetine was administered at the discretion of treating providers with data gathered retrospectively." | 1.51 | Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. ( Abzug, MJ; Bains, HK; Benson, LA; DeBiasi, RL; Desai, J; Dominguez, SR; Glanternik, JR; Gorman, MP; Hopkins, SE; Hurst, AL; Kruer, MC; Makhani, N; Martin, JA; Messacar, K; Otten, C; Santoro, JD; Schreiner, T; Sillau, S; Torres, A; Treister, A; Tremoulet, AH; Tyler, KL; Van Haren, K; Wilson-Murphy, M; Wong, B; Zabrocki, L, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matesanz, S | 1 |
| McGuire, JL | 1 |
| Hopkins, S | 1 |
| Hixon, AM | 1 |
| Clarke, P | 1 |
| Tyler, KL | 3 |
| Messacar, K | 1 |
| Sillau, S | 1 |
| Hopkins, SE | 1 |
| Otten, C | 1 |
| Wilson-Murphy, M | 1 |
| Wong, B | 1 |
| Santoro, JD | 1 |
| Treister, A | 1 |
| Bains, HK | 1 |
| Torres, A | 1 |
| Zabrocki, L | 1 |
| Glanternik, JR | 1 |
| Hurst, AL | 1 |
| Martin, JA | 1 |
| Schreiner, T | 1 |
| Makhani, N | 1 |
| DeBiasi, RL | 1 |
| Kruer, MC | 1 |
| Tremoulet, AH | 1 |
| Van Haren, K | 1 |
| Desai, J | 1 |
| Benson, LA | 1 |
| Gorman, MP | 1 |
| Abzug, MJ | 1 |
| Dominguez, SR | 1 |
4 other studies available for fluoxetine and Infectious Myelitis
| Article | Year |
|---|---|
Acute Flaccid Myelitis: Characteristics and Outcomes of 2014 and 2016 Cases at a Single Center.
Topics: Brain; Central Nervous System Viral Diseases; Child; Child, Preschool; Diagnostic Errors; DNA, Viral | 2019 |
Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Dexamethasone; Disease Models, Animal; Enterov | 2017 |
Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis.
Topics: Antiviral Agents; Central Nervous System Viral Diseases; Child; Child, Preschool; Female; Fluoxetine | 2019 |
Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Child; Drug Discovery; Enterovirus D, Human; Flu | 2015 |